NCT00423488 - Ezetimibe and Simvastatin in Primary Hypercholesterolemia, Diabetes Mellitus Type 2, and Coronary Heart Disease (COMPLETED) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 12, 2005

Primary Completion Date

February 16, 2007

Study Completion Date

February 16, 2007

Conditions

HypercholesterolemiaDiabetes Mellitus, Type 2Coronary Disease

Interventions

DRUG

Ezetimibe 10 mg

1 x 10-mg tablet, provided as blinded study treatment

DRUG

Simvastatin 20 mg

1 x 20-mg tablet, provided as open-label study treatment

DRUG

Ezetimibe Placebo

1 tablet matching ezetimibe 10-mg tablet, provided as blinded study treatment

DRUG

Simvastatin 20 mg

1 x 20-mg tablet, provided as blinded study treatment

DRUG

Simvastatin Placebo

1 tablet matching 20-mg simvastatin tablet, provided as blinded study treatment